| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.038 | 0.8 |